Bpifrance, a provider of financial solutions for companies, led a €15m Series B round in Tribune Health, a developer of software solutions for digital pathology, with participation from Owkin, Vivalto Partners, and LBO France. "We are honoured to be selected for the French Tech 2030 program, which recognizes our commitment to innovation and our impact on the health organization, providing solutions to improve the speed and the precision of cancer diagnosis. The provided support will enable us to push the boundaries of our AI-powered pathology platform, amplify our market reach, and make meaningful strides in the global healthcare landscape," Jean-François Pomerol, Tribun Health CEO.